Johnson & Johnson (JNJ) Tops Q2 EPS by 6c; Boosts FY16 Outlook

Johnson & Johnson (NYSE: JNJ) reported Q2 EPS of $1.74, $0.06 better than the analyst estimate of $1.68. Revenue for the quarter came in at $18.5 billion versus the consensus estimate of $17.98 billion.

GUIDANCE:

Johnson & Johnson sees FY2016 EPS of $6.63-$6.73, versus the consensus of $6.61. Johnson & Johnson sees FY2016 revenue of $71.5-72.2 billion, versus the consensus of $71.7 billion.

For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Franklin Covey (FC) Misses Q3 EPS by 2c, lowers Guidance
• Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity